Evaluation of bioreductive drugs in multicell spheroids
- 31 December 1992
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 22 (4) , 689-692
- https://doi.org/10.1016/0360-3016(92)90504-b
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Radiosensitisation and radioprotection by BSO and WR-2721: the role of oxygenationBritish Journal of Cancer, 1989
- Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxinsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Pre- and post-irradiation adiosensitization by SR 4233International Journal of Radiation Oncology*Biology*Physics, 1989
- Cytotoxicity of rsu 1069 in spheroids and murine tumorsInternational Journal of Radiation Oncology*Biology*Physics, 1987
- SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cellsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Evidence suggesting that the mechanism for aerobic and hypoxic cytotoxicity of nitroheterocycles is the sameInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Use of Hoechst 33342 for cell selection from multicell systems.Journal of Histochemistry & Cytochemistry, 1982
- Evaluation of Nitroheterocyclic Radiosensitizers Using SpheroidsPublished by Elsevier ,1981
- Bioactivation as a Model for Drug Design Bioreductive AlkylationScience, 1977
- Radiosensitizing and Toxic Effects of the 2-Nitroimidazole Ro-07-0582 in Hypoxic Mammalian CellsRadiation Research, 1976